These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 38821167)
1. A systematic review of novel cannabinoids and their targets: Insights into the significance of structure in activity. Abdollahzadeh Hamzekalayi MR; Hooshyari Ardakani M; Moeini Z; Rezaei R; Hamidi N; Rezaei Somee L; Zolfaghar M; Darzi R; Kamalipourazad M; Riazi G; Meknatkhah S Eur J Pharmacol; 2024 Aug; 976():176679. PubMed ID: 38821167 [TBL] [Abstract][Full Text] [Related]
2. Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products. An D; Peigneur S; Hendrickx LA; Tytgat J Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709050 [TBL] [Abstract][Full Text] [Related]
3. Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists. Marusich JA; Wiley JL; Lefever TW; Patel PR; Thomas BF Neuropharmacology; 2018 May; 134(Pt A):73-81. PubMed ID: 29113898 [TBL] [Abstract][Full Text] [Related]
4. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB Grafinger KE; Cannaert A; Ametovski A; Sparkes E; Cairns E; Banister SD; Auwärter V; Stove CP Drug Test Anal; 2021 Jul; 13(7):1402-1411. PubMed ID: 33769699 [TBL] [Abstract][Full Text] [Related]
5. Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists. Patel M; Manning JJ; Finlay DB; Javitch JA; Banister SD; Grimsey NL; Glass M Biochem Pharmacol; 2020 May; 175():113871. PubMed ID: 32088263 [TBL] [Abstract][Full Text] [Related]
6. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction. Shim JY; Welsh WJ; Howlett AC Biopolymers; 2003; 71(2):169-89. PubMed ID: 12767117 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and SAR evaluation of coumarin derivatives as potent cannabinoid receptor agonists. Mohr F; Hurrle T; Burggraaff L; Langer L; Bemelmans MP; Knab M; Nieger M; van Westen GJP; Heitman LH; Bräse S Eur J Med Chem; 2021 Aug; 220():113354. PubMed ID: 33915369 [TBL] [Abstract][Full Text] [Related]
9. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB Pike E; Grafinger KE; Cannaert A; Ametovski A; Luo JL; Sparkes E; Cairns EA; Ellison R; Gerona R; Stove CP; Auwärter V; Banister SD Drug Test Anal; 2021 Jul; 13(7):1383-1401. PubMed ID: 33787091 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse. Vasiljevik T; Franks LN; Ford BM; Douglas JT; Prather PL; Fantegrossi WE; Prisinzano TE J Med Chem; 2013 Jun; 56(11):4537-50. PubMed ID: 23631463 [TBL] [Abstract][Full Text] [Related]
19. Cannabichromene is a cannabinoid CB Udoh M; Santiago M; Devenish S; McGregor IS; Connor M Br J Pharmacol; 2019 Dec; 176(23):4537-4547. PubMed ID: 31368508 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoids and their actions. Alexander SP; Randall M Br J Pharmacol; 2007 Nov; 152(5):557-8. PubMed ID: 17891156 [No Abstract] [Full Text] [Related] [Next] [New Search]